LifeMD, Inc. (LFMD)
2.955
-0.14
(-4.37%)
USD |
NASDAQ |
Sep 09, 16:00
2.955
0.00 (0.00%)
After-Hours: 17:07
LifeMD EPS Diluted (Quarterly) : -0.1645 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1645 |
| March 31, 2026 | -0.2038 |
| December 31, 2025 | -0.0486 |
| September 30, 2025 | -0.0993 |
| June 30, 2025 | -0.054 |
| March 31, 2025 | -0.0223 |
| December 31, 2024 | -0.1354 |
| September 30, 2024 | -0.1293 |
| June 30, 2024 | -0.1853 |
| March 31, 2024 | -0.1923 |
| December 31, 2023 | -0.1228 |
| September 30, 2023 | -0.2001 |
| June 30, 2023 | -0.2306 |
| March 31, 2023 | -0.151 |
| December 31, 2022 | -0.4047 |
| September 30, 2022 | -0.2605 |
| June 30, 2022 | -0.4478 |
| March 31, 2022 | -0.4562 |
| December 31, 2021 | -0.6209 |
| September 30, 2021 | -0.5379 |
| June 30, 2021 | -0.6402 |
| March 31, 2021 | -0.4742 |
| December 31, 2020 | -2.563 |
| September 30, 2020 | -1.649 |
| June 30, 2020 | -0.2736 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2238 |
| December 31, 2019 | -0.0672 |
| September 30, 2019 | -0.0931 |
| June 30, 2019 | -0.0872 |
| March 31, 2019 | -0.0709 |
| December 31, 2018 | -0.085 |
| September 30, 2018 | -0.118 |
| June 30, 2018 | -0.05 |
| March 31, 2018 | 0.05 |
| December 31, 2017 | -0.025 |
| September 30, 2017 | -0.0831 |
| June 30, 2017 | 0.10 |
| March 31, 2017 | -0.15 |
| December 31, 2016 | -0.0878 |
| September 30, 2016 | -0.05 |
| June 30, 2016 | -0.05 |
| March 31, 2016 | -0.0097 |
| December 31, 2015 | -0.008 |
| September 30, 2015 | 0.0014 |
| June 30, 2015 | -0.0034 |
| March 31, 2015 | 0.0002 |
| December 31, 2014 | -0.0234 |
| September 30, 2014 | -0.0171 |
| June 30, 2014 | -0.0118 |
| March 31, 2014 | -0.0234 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biotricity, Inc. | -0.0463 |
| Aclarion, Inc. | -1.116 |
| Establishment Labs Holdings, Inc. | -0.39 |
| Agilent Technologies, Inc. | 1.279 |
| Abbott Laboratories | 0.5324 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.084M |
| Revenue (Quarterly) | 47.28M |
| Total Expenses (Quarterly) | 54.36M |
| Enterprise Value | 128.64M |
| Gross Profit Margin (Quarterly) | 79.67% |
| Profit Margin (Quarterly) | -14.98% |
| Earnings Yield | -17.47% |
| Normalized Earnings Yield | -16.88 |